Visiopharm is pleased to announce that Johanne Louise Brændgaard has been appointed Chief Marketing Officer.
Johanne will play a vital part in executing Visiopharm’s strategy in AI-driven precision and high-throughput pathology, with responsibility for brand strategy and awareness, customer experience and commercial marketing.
Johanne brings extensive global experience of sales, marketing, and product management within the medical technology industry from previous positions at Cook Medical and Getinge. She also has experience from the telecommunications and venture capital industries.
Johanne is currently on the board of ADDvise AB, having previously been on the board of Acarix AB.
Johanne has a master’s degree in International Business Economics from Aalborg University in Denmark.
Michael Grunkin, Visiopharm CEO said:
“We are delighted to welcome Johanne. She is a great fit with the team, culture and values of the company and brings a personality with her that will naturally facilitate cross-functional collaboration. That, in combination with her extensive experience in the medical technology industry, will be a great asset as we continue to move forward with our ambitious marketing goals.”
Johanne Louise Brændgaard said:
“I’m excited to have joined Visiopharm at this critical time and be part of the mission to transform pathology through our AI-driven solutions. This will enable our customers to have a much stronger foundation for making diagnostic and treatment decisions for cancer patients, which in turn can have significant socio-economic impact due to lower rates of misdiagnosis and ineffective treatment.”